Narcotics: all 1,909 studies that test it
Page 19 of 20. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- A Study of the Effect on Pain Control of Treatment With Fentanyl, Administered Through the Skin, Compared With Placebo in Patients With OsteoarthritisCompletedNCT00236366Phase 4
- Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer PainTerminatedNCT00236327Phase 4
- Evaluate the Efficacy and Safety of ACTIQ in Patients With Cancer and Breakthrough PainCompletedNCT00236145Phase 3
- Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)CompletedNCT00236041Phase 2
- Genetic Determinants of Opioids AnalgesiaCompletedNCT00226564Not applicable
- Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant PainCompletedNCT00226421Phase 3
- Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant PainCompletedNCT00225797Phase 3
- Buprenorphine as a Treatment for Individuals Dependent on Analgesic OpioidsCompletedNCT00218101Phase 2
- Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and PharmacokineticsCompletedNCT00216684Phase 3
- Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -CompletedNCT00216658Phase 2
- Intravenous and Topical Analgesics for Procedural Pain in NeonatesCompletedNCT00213200Phase 3
- A Study Comparing the Effectiveness and Safety of Tramadol HCl/Acetaminophen Versus Placebo for the Treatment of Painful Neuropathy in Diabetic PatientsCompletedNCT00210847Phase 3
- A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back PainTerminatedNCT00210561Phase 4
- Postoperative Pain Control After Kidney Surgery : a Comparison of Intrathecal Morphine Plus PCA and PCA OnlyStatus unknownNCT00199316Not applicable
- Safety and Efficacy Study of Hydromorphone and MorphineCompletedNCT00195910Phase 2
- Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic StudyCompletedNCT00184496Phase 3
- Efficacy of Transdermal Fentanyl for Chronic Neuropathic PainCompletedNCT00181246Not applicable
- Topical Hydromorphone for Wound HealingTerminatedNCT00177060Phase 1/2
- NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate AddictionCompletedNCT00175357Phase 3
- Codeine in Sickle Cell DiseaseCompletedNCT00174538Phase 1/2
- Neuraxial Pethidine After Lumbar Surgery TrialStatus unknownNCT00163553Phase 3
- Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid UsersCompletedNCT00158236Not applicable
- Intravenous-Morphine and Glucagon-Usage Enhanced MR CholangiographyStatus unknownNCT00155376Phase 4
- Interaction Between Nalbuphine and Morphine in PCAStatus unknownNCT00155233Phase 4
- Combined Spinal-Epidural Versus Traditional Labor EpiduralCompletedNCT00151346Phase 4
- Abuse Potential of Buprenorphine/NaloxoneTerminatedNCT00149539Phase 2
- Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 SubstudyTerminatedNCT00147355Phase 3
- Tramadol to Reduce Opioid Withdrawal SymptomsCompletedNCT00142896Phase 2
- Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid DependenceCompletedNCT00134914Not applicable
- Blockade Efficacy of Buprenorphine/Naloxone For Opioid DependenceCompletedNCT00134888Not applicable
- Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid AbusersTerminatedNCT00134875Not applicable
- Bioavailability and Effectiveness of Transdermally Administered MorphineCompletedNCT00125684Phase 1
- Sublingual Methadone for the Management of Cancer Breakthrough PainCompletedNCT00125294Phase 1
- Buprenorphine and Integrated HIV Care EvaluationStatus unknownNCT00124358Phase 4
- Pain Relief - Tramadol Versus IbuprofenStatus unknownNCT00111046Phase 1/2
- Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1CompletedNCT00078130Phase 3
- Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1CompletedNCT00078117Phase 3
- Buprenorphine/Naloxone Versus Clonidine for Outpatient Opiate Detoxification - 1CompletedNCT00032968Phase 3
- Buprenorphine/Naloxone Versus Clonidine for Inpatient Opiate Detoxification - 1CompletedNCT00032955Phase 3
- Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1CompletedNCT00023283Phase 2
- Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough PainCompletedNCT00020618Phase 2
- Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14CompletedNCT00015340Phase 4
- Buprenorphine and Naloxone Combination Study - 10CompletedNCT00015288Phase 1
- Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1CompletedNCT00015171Phase 3
- Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2CompletedNCT00015041Phase 1
- Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1CompletedNCT00015028Phase 2
- Pain Treatment for SciaticaCompletedNCT00009672Phase 2
- Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based PracticeCompletedNCT00007527Phase 4
- Treatment of Chronic Pain After Spinal Cord Injury (SCI) or AmputationCompletedNCT00006448Not applicable
- Study of Morphine in Postoperative Infants to Allow Normal VentilationCompletedNCT00004696Not applicable
- Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation TherapyCompletedNCT00004424Not applicable
- Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic NeuralgiaCompletedNCT00004390Phase 3
- Treatment for Chronic Pain in Patients With Advanced CancerCompletedNCT00003687Phase 3
- Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical ProstatectomyCompletedNCT00003115Phase 3
- A Study of Azidothymidine Plus Methadone in Patients With AIDS and AIDS Related Complex (ARC)CompletedNCT00001008Not applicable
- Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected PatientsCompletedNCT00000906Phase 1
- Methadone Effects on Zidovudine (ZDV, AZT) DispositionCompletedNCT00000800Phase 1
- A Study to Assess the Effect of Concomitant Administration of Fluconazole on the Clinical Pharmacokinetics of MethadoneCompletedNCT00000788Phase 1
- Buprenorphine Maintenance for Opiate Dependence - 6CompletedNCT00000357Phase 2
- Effects of Buprenorphine and Naloxone in Opiate Addicts - 4CompletedNCT00000355Phase 1
- Trial of Buprenorphine/Naloxone for Opiate Dependence - 2CompletedNCT00000353Phase 2
- Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9CompletedNCT00000344Phase 2
- Evaluation of Liquid vs. Tablet Buprenorphine - 6CompletedNCT00000341Phase 2
- Activity Monitoring Assessment of Opiate Withdrawal - 4CompletedNCT00000335Phase 2
- Comparison of Buprenorphine and Methadone - 3CompletedNCT00000334Phase 2
- Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1CompletedNCT00000320Phase 1/2
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2CompletedNCT00000319Phase 2
- Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1CompletedNCT00000318Phase 2
- Combining Behavioral Treatment With Agonist Maintenance - 1CompletedNCT00000311Phase 3
- Study Comparing Liquid and Tablet Buprenorphine Formulations - 5CompletedNCT00000302Phase 3
- Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2CompletedNCT00000299Phase 2
- Buprenorphine Combination Tablet Feasibility - 1CompletedNCT00000298Phase 2
- A Laboratory Model for Heroin Abuse Medications - 8CompletedNCT00000273Phase 2
- Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on MethadoneTerminatedNCT00000243Not applicable
- Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22CompletedNCT00000240Phase 2
- Buprenorphine Pharmacology Related to Addiction Treatment - 21CompletedNCT00000239Phase 2
- Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20CompletedNCT00000238Phase 2
- Buprenorphine Detoxification - BBDVI - 19CompletedNCT00000237Phase 2
- Buprenorphine Pharmacology Related to Addiction Treatment - 18CompletedNCT00000236Phase 2
- Alternate Day Buprenorphine Administration, Phase XII - 17CompletedNCT00000235Phase 2
- Alternate Day Buprenorphine Administration, Phase XI - 16CompletedNCT00000234Phase 2
- Alternate Day Buprenorphine Administration, Phase X - 15CompletedNCT00000233Phase 2
- Alternate Day Buprenorphine Administration, Phase IX - 14CompletedNCT00000232Phase 2
- Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13CompletedNCT00000231Phase 2
- Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12CompletedNCT00000230Phase 2
- Buprenorphine Detox With Two Types of Treatment. BBD II - 11CompletedNCT00000229Phase 2
- Buprenorphine Detox With Two Types of Treatment. BBD I - 10CompletedNCT00000228Phase 2
- Alternate-Day Buprenorphine Administration. Phase VIII - 9CompletedNCT00000227Phase 2
- Alternate-Day Buprenorphine Administration. Phase VII - 8CompletedNCT00000226Phase 2
- Alternate-Day Buprenorphine Administration. Phase VI - 7CompletedNCT00000225Phase 2
- Alternate-Day Buprenorphine. Phase V - 6CompletedNCT00000224Phase 1
- Alternate-Day Buprenorphine Administration. Phase IV - 5CompletedNCT00000223Phase 2
- Alternate-Day Buprenorphine Administration. Phase II - 4CompletedNCT00000222Phase 1
- Alternate-Day Buprenorphine Administration. Phase I - 3CompletedNCT00000221Phase 1
- Gradual Vs. Rapid Buprenorphine Detoxification - 2CompletedNCT00000220Phase 1
- Buprenorphine Dose Alteration Study - 1CompletedNCT00000219Phase 1
- Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1CompletedNCT00000216Phase 3
- IV Cocaine Abuse: A Laboratory Model - 3CompletedNCT00000214Phase 2
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 2CompletedNCT00000211Phase 2
- Treatment Efficacy for Drug Abuse and AIDS Prevention - 1CompletedNCT00000210Phase 2